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Appendix 
I. Assisted function and peripheral stimulation 
While electrical stimulation has been in clinical use for half a century, most of the early applications 
targeted the peripheral nervous system (or peripheral musculature directly) with the aim of replacing 
activity lost through injury or disease, and thereby restoring some of the lost function, the classic 
example being electrical stimulation of peroneal nerves to treat foot drop and improve walking after 
brain damage or SCI. Over time, the range and complexity of these peripheral interventions has 
increased, along with strong clinical evidence of their effectiveness (and limitations), as we discuss 
below.  
Stimulation of the peripheral nervous system, using neuroprosthetic technology to activate 
either motor or sensory nerves, represents the most clinically accessible and well tested form of 
neuromodulation. Beyond the effects at the muscle and spinal levels, peripheral stimulation can also 
influence motor function by increasing cortical excitability. A detailed description of the history of 
these developments is beyond the scope of this review (for recent reviews see1–3). Here we summarise 
the current state of this field and the new issues it is addressing.   
Functional electrical stimulation (FES), where small electrical pulses are applied to muscles or 
nerves to improve their function, has a long history and clear benefits1 in comparison with, for 
instance, treadmill-based training. Indirect muscle activation can be achieved by stimulating sensory 
nerves to evoke a spinal reflex response, and regular use of this type of stimulation is associated with 
improved voluntary activation of the dorsiflexors, as well as more normal modulation of spinal reflex 
circuity4. With the advent of locomotor exoskeletons, emerging technology integrates FES muscle 
activation with mechanical robotic support5. These advances combine the advantage of structural 
support for the stance phase of walking, with stepping activity driven by stimulated muscle function. 
This combined approach increases the potential value of exoskeletons as rehabilitation tools, since 
they more actively engage the nervous system in the walking behaviour. Beyond walking function, 
there are recent efforts to use neuroprosthetic systems to improve hand and arm function in persons 
with SCI6,7. For this to be of value, there are at least two requirements that must be met. First, for 
muscles to be responsive to electrical stimulation, some of the spinal motor neurons innervating the 
muscle targeted by the stimulation must be intact. Second, for grasp to be functionally meaningful, it 
is necessary that the individual have sufficient volitional control of the more proximal muscles about 
the elbow and shoulder in order to transport the hand to the object. As with exoskeletons for walking 
function, there is emerging technology, recently applied in participants severely affected by stroke, 
that integrates exoskeletal assistance and multi-channel neuromuscular stimulation to support upper 
extremity reach-to-grasp movements during rehabilitation exercises8. This type of “closed loop 
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training environment” has clear applications for SCI, and further developments in closed loop systems 
which use decoded brain signals to activate peripheral muscles involved in reach and grasp9,10 are 
discussed in section V below. 
An alternative to the use of motor stimulation for its neuroprosthetic applications is the use 
of somatosensory stimulation to promote functional restoration by “priming”11 cortical networks, and 
thereby increasing corticospinal excitability. The reduced rate and volume of corticospinal 
transmission associated with damage to the spinal cord is a primary contributor to impaired hand 
function after SCI12. The situation is further complicated by the maladaptive cortical reorganization 
that accompanies SCI. While maladaptive cortical reorganization has not been studied in persons with 
SCI to the extent it has been studied in persons with stroke, early evidence indicates that motor 
recovery after SCI is associated with cortical and spinal cord structural and functional reorganization13. 
There is a direct relationship between the level of functional connectivity and recovery of motor 
function in persons with SCI14. By increasing cortical excitability and promoting neuroplasticity through 
motor practice, it is possible to increase corticospinal transmission in persons with SCI. Among the 
more accessible approaches to increasing cortical excitability is the use of electrical stimulation to 
activate sensory pathways peripherally. In persons with tetraplegia who have sufficient corticospinal 
connectivity to achieve at least a minimal amount of voluntary thenar muscle activation, 
somatosensory stimulation combined with training is associated with improvements in grasp strength 
that exceed those of resistance training15. Based on the goal of increasing transmission through 
remaining descending pathways, an ongoing clinical trial (NCT02611375; see Table 1 and16) compares 
the relative value of different forms of stimulation (peripheral nerve stimulation versus transcranial 
direct current stimulation, with both groups compared to sham stimulation) for augmenting the 
effects of conventional fine motor training. Since both forms of stimulation are clinically accessible, 
and the study is designed as a pragmatic clinical trial performed in the real-world clinical setting the 
outcome is expected to have immediate applicability for clinical practice. 
 Achieving recovery and control of basic bodily functions, such as bladder and bowel 
continence, - and in persons with high cervical SCI, respiration -, is the highest shared priority of 
persons with paraplegia and tetraplegia and rated as important as recovering lower limb movement. 
The Finetech-Brindley sacral anterior root stimulation (SARS) device, an implantable neuroprosthesis 
providing electrical stimulation of the motor nerves innervating the bladder and bowel, has been in 
clinical use since the 1970’s. This device marked a breakthrough in incontinence management, 
enabling effective bladder voiding as well as aiding bowel evacuation and penile erection. However, 
its wider use has been limited by the surgical procedures and their complications, requiring 
irreversible removal of sacral sensory nerve roots (posterior rhizotomy) to prevent spontaneous 
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voiding and sphincter dyssynergia. Another early approach involved electrical stimulation of sacral 
nerves, leading to the development of a sacral nerve neuromodulation device (Medtronic Interstim) 
which has also been shown to successfully improve bladder continence in SCI patients. The use of 
these implantable devices, and more recent iterations such as the extradural (SPARSI) and intrathecal 
(SPAIRS) sacral posterior and anterior root stimulator implants, which do not involve posterior 
rhizotomy, has recently been reviewed in detail17. Another area receiving considerable current 
attention is the possibility of treating pain associated with SCI, and indeed other pathologies, with 
electrical stimulation of the dorsal root ganglion (where the cell bodies of sensory neurons are 
located). There is a commercial development in this area and a number of ongoing clinical trials, 
although clinical trial data is not yet available and the mechanism of action is not known. It should be 
noted that clinical applications of these new developments will be dependent on maintaining the 
skillset of clinicians willing to perform these procedures and of course by convincing clinical studies on 
efficacy. In individuals with high cervical SCI, in whom diaphragmatic innervation is lost, diaphragmatic 
pacing stimulation (DPS) can be a viable alternative to breathing through mechanical ventilation. 
Depending on the approach, stimulating cuff electrodes are placed around the phrenic nerve 
(intrathoracic diaphragm pacing), or electrodes are placed in the diaphragm (intraperitoneal diaphragm 
pacing). Following participation in a diaphragm reconditioning program, over 70% of the individuals 
who have received these implants have been successfully weaned from mechanical ventilation18.  
 
Experimental advances in peripheral stimulation 
Novel applications of peripheral neuromodulation are being explored in laboratory 
experiments, such as the recent application of a “closed-loop” neuroprosthetic interface which was 
designed to measure bladder fullness and prevent spontaneous voiding episodes without the need for 
dorsal rhizotomy in adult SCI rats19. Accurate recordings of bladder filling were achieved by implanting 
fine-diameter sensory nerve ''rootlets'' into insulated microchannels. This sensory feedback was 
utilised to adjust ventral root stimulation and modulate bladder emptying, which could be artificially 
stimulated on demand by electrically modulating nerve firing. The clinical translation of this approach 
is currently limited by challenges in maintaining stable sensory recordings long-term. Recently, 
embryonic stem cell-derived motor neurons implanted into denervated peripheral nerves in mice 
were shown to innervate skeletal muscle and optogenetic stimulation of the motor neurons led to 
active contractions in the muscle20. While far from clinical application, this highlights recent advances 
in stem cell biology which have potential future applications for ‘neuronal circuit building’ to 
reanimate denervated muscles. 
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II. Clinical application of neuromodulation approaches for spinal cord injury 
Challenges 
The main challenges to achieving widespread clinical application of neuromodulation for SCI outlined 
in Panel 1 relate to considerations regarding accessibility, affordability, durability, feasibility and 
scalability of the approaches, but also a deeper understanding of mechanisms will be crucial to 
realising the full potential of neuromodulation-based interventions, as will the appropriate clinical trial 
design to enable large-scale clinical trials, which are needed to fully evaluate treatment efficacy. An 
important consideration in relation to scalability (which also relates to accessibility, affordability and 
feasibility) is the relative cost and healthcare infrastructure required for the different interventions. 
Some neuromodulation interventions are inexpensive and use conventional, commercially available 
stimulation devices, enabling their widespread use, as is the case for peripheral stimulation devices. 
However, newer advances in peripheral stimulation techniques which integrate FES with exoskeletal 
assistance5 will not be so easily scalable due to the high costs of dexterous robotic devices. tcSCS and 
tDCS both have the potential to be rapidly made available to persons with SCI on a large scale, offering 
cost eﬃcient and safe approaches to treating SCI, although robust evidence for functional 
improvements with these methods is not yet available. Perhaps the most dramatic demonstrations of 
return of function have been with BMI approaches, which in several small-scale studies have enabled 
reach and grasp movements in persons with chronic tetraplegia10,21. However, these are the most 
challenging in terms of scalability since they require specialized equipment and expertise and complex 
and non-portable systems which, together with extremely high costs and a lack of large-scale 
commercial interest22, precludes their widespread use. While this may improve as technology 
becomes more affordable and portable, this currently preludes large-scale clinical trials, the lack of 
which arguably remains the biggest challenge for widespread clinical application of neuromodulation 
for SCI. A further important challenge in relation to future clinical trial design is identifying the 
appropriate populations for enrollment, as discussed below. 
A further consideration when implementing any neuromodulatory intervention is determining 
the optimal timing, both in terms of which stage of injury will neuromodulation be most effective, and 
in terms of timing of multiple interventions. Evidence suggests that brain and spinal cord 
reorganization early after injury are correlated with the amount of recovery14, which would suggest 
that interventions may have greater effect in the early stages after injury. Indeed, there is some 
evidence to support the concept that greater effects are achieved earlier after spinal cord injury in 
human studies, however there is also potential for improvements even in the chronic stage many 
years after injury (for review see23).  Furthermore, recent experimental work revealed the importance 
of sequential (rather than concurrent) timing of multiple neuromodulatory interventions. When 
5 
 
animals with experimental stroke24 or SCI25 were treated with a neuroplasticity-enhancing anti-Nogo 
immunotherapy combined with rehabilitation, early high-intensity training during the 2 week 
immunotherapy dosing period (the active axonal growth phase) led to poorer performance than each 
therapy alone. However, sequential therapy, which enabled active growth and then stabilisation 
before commencing intensive training, led to significant recovery of motor functions. This highlights 
the need to consider whether to apply neuromodulation interventions during a “plastic” vs 
stabilisation phase in future study designs. There are different views regarding the relative timing of 
neuromodulatory stimulation and training, as there are thought to be two classes of mechanisms that 
govern decisions about timing of the stimulation relative to training. The principles of homeostatic 
plasticity would dictate that inhibitory stimulation be used in advance of training, whereby the 
mechanism of returning excitability to pre-stimulation levels would be synergistic with the activity-
related increase in excitability. Conversely, principles of gating would dictate that excitatory 
stimulation be used concurrently with training such that the two mechanisms would have an additive 
effect11. More work is needed on establishing the optimal timing for neuromodulation-based 
interventions for SCI and, again, understanding mechanisms will be of critical importance.  
 
Clinical trial design for neuromodulation interventions for SCI 
The great variability in clinical presentation of SCI is one of the major challenges in identifying 
stimulation-based interventions that have broad applicability. Functional movement is strongly 
dependent of the amount of descending corticospinal activation that reaches the spinal circuits to 
activate muscles response, this is true for hand function26 as well as walking function27.  The 
International Standards for Neurological Classification of Spinal Cord Injury28 classifies SCI into 
“complete” (insufficient residual spinal transmission pathways to allow sensory perception or 
volitional movement) and “incomplete” (some degree of residual spinal transmission to allow sensory 
perception or volitional movement). In addition, there is evidence that some individuals who appear 
to have complete SCI, do in fact have some residual remaining transmission that is evident on 
electrophysiologic assessment, a phenomenon referred to as ”discomplete” SCI29. Following SCI, the 
nervous system undergoes many changes, and these changes may progress at different rates in 
different individuals. Despite this potential for neurologic change, large longitudinal studies have 
indicated that electrophysiologic measures acquired early after SCI strongly predict motor scores and 
functional abilities at one-year post SCI for both upper and lower extremities30,31. Future studies will 
need to determine which interventions have the most beneficial influence on these outcomes. 
The majority of clinical trials that use stimulation approaches for restoration of motor function 
enrol individuals who have sufficient residual spinal transmission for some degree of volitional 
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movement. While there are exceptions, to date those studies that have enrolled individuals with 
complete or discomplete injuries have shown that while it is possible to elicit movement, the 
technology has yet to facilitate the amount of motor activation that is required for functional hand or 
lower extremity activity. The differences in the requirements to achieve functional hand or lower 
extremity movement between persons with more severe SCI who lack volitional control and persons 
with residual volitional control indicates that research approaches for these two sub-populations must 
differ. For studies in persons with insufficient residual spinal cord transmission to produce movement, 
the goal is to demonstrate proof-of-concept for the potential of an intervention to influence 
movement that is supportive of real-world function (e.g. hand grasp, stepping, sitting balance). 
Conversely, for studies in individuals with residual volitional control that are intended to assess the 
rehabilitation value of an intervention, the intervention must be associated with a meaningful 
improvement in ability to perform an activity.  There are valuable recommendations available to guide 
the development of the latter type of clinical trials from the proof-of-concept stage to clinical efficacy 
stage32. It is important to recognize that even large multicentre efficacy studies, wherein an 
experimental intervention is compared to a viable control condition, have criteria and restrictions that 
may limit direct translation to the real world of the clinic. As such these trials, at best, show efficacy 
rather than effectiveness. Effectiveness of any intervention can only be shown based on the value of 
the intervention under real-world clinical conditions. For this reason, there is growing interest in 
pragmatic clinical trials, wherein an experimental intervention is included as part of real-world clinical 
practice to evaluate its effectiveness. 
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